Where next for these 2 FTSE 100 retailers?
Robert Stephens considers what the future could hold for two of the UK's biggest brick and mortar retailers.
3 years ago
Latest
Town Centre Securities – a temporary profits blip shows up good buying opportunity
As shoppers head back to the town centre, Mark Watson-Mitchell wonders if investors should follow suit.
3 years ago
Crossing the chasm – a key step on the longevity investment journey
Find out more about First Longevity ahead of George Sutherland’s presentation at Master Investor’s Investing in the Age of Longevity…
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
Buying opportunity for the Biotech Growth Trust
Does Biotech Growth Trust's recent share price weakness offer a decent entry point for long-term investors?
3 years ago
De-risking rejuvenation therapy could be seismic Shift for longevity
Discover more about Shift Bioscience ahead of Daniel Ive's presentation at Master Investor's Investing in the Age of Longevity event.
3 years ago
Evil Diaries: When smoke gets in your buys
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago
Monday Morning Round-up
Mark Watson-Mitchell proves a quick round-up of three previous profile stocks for the start of the week.
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
COP26 Week 2 – Turning Point or Failure?
The purpose of COP26 was to formulate initiatives that would decelerate global warming and make the politicians feel good about…
3 years ago